TOKYO, June 25 (Xinhua) — Tokyo stocks closed higher Friday following an upbeat lead from Wall Street overnight, although concerns over Japan’s rising COVID-19 cases ahead of the Olympics to be held in the capital in less than a month capped gains.<\/p>\n\n\n\n
The 225-issue Nikkei Stock Average added 190.95 points, or 0.66 percent, from Thursday to close the day at 29,066.18.<\/p>\n\n\n\n
The broader Topix index of all First Section issues on the Tokyo Stock Exchange, meanwhile, gained 15.55 points, or 0.80 percent, to finish at 1,962.65.<\/p>\n\n\n\n
Local brokers said investors cheered U.S. stocks gaining ground overnight, which boosted cyclical and technology issues here.<\/p>\n\n\n\n
They added, however, the market’s upside was capped by concerns Japan’s COVID-19 pandemic could worsen as new infections are on the rise, with the Tokyo Olympics and Paralympics set to start in less than a month.<\/p>\n\n\n\n
“Today’s market is tracking Wall Street’s strong gains. But investors, particularly in Japan, are getting wary of U.S. markets taking a pause anytime soon,” Shoichi Arisawa, general manager of the investment research department at IwaiCosmo Securities, was quoted as saying.<\/p>\n\n\n\n
“Prospects of an economic recovery in Japan are getting unclear as the number of new COVID-19 infections is on the rise again, and the pandemic could worsen as the country plans to conduct the Olympics,” Arisawa added.<\/p>\n\n\n\n
By the close of play, issues that rose outpaced those that fell by 1,595 to 504 on the First Section, while 94 ended the day unchanged.<\/p>\n\n\n\n
The U.S. dollar’s comparative strength against the Japanese yen, with the greenback trading in the upper 110-yen zone, helped lift exporters who are typically reliant on a weaker yen to boost profits when repatriated.<\/p>\n\n\n\n
Panasonic climbed 4.9 percent, following reports it had sold its entire stake in U.S. electric vehicle maker Tesla Inc. last fiscal year.<\/p>\n\n\n\n
Mazda Motor Corp., meanwhile, soared 8.7 percent, to become the Nikkei’s biggest gainer.<\/p>\n\n\n\n
Chip-related issues followed their U.S. peers higher, with Tokyo Electron adding 0.7 percent, while Advantest rose 1.5 percent.<\/p>\n\n\n\n
Industrial robotics maker Fanuc, for its part, ended the day 1.7 percent higher.<\/p>\n\n\n\n
Among cyclical issues finding traction, steelmakers attracted buying.<\/p>\n\n\n\n
JFE Holdings jumped 4.2 percent, Nippon Steel closed up 4.4 percent, while Kobe Steel advanced 4.8 percent.<\/p>\n\n\n\n
Toshiba was a notable loser, dropping 0.6 percent, following its shareholders on Friday voting to oust its board chairman and another director following a major governance and government-implicated collusion scandal.<\/p>\n\n\n\n
On the main section on Friday, 904.26 million shares changed hands, rising from Thursday’s volume of 842.48 million shares.<\/p>\n\n\n\n
The turnover on the final trading day of the week came to 2,142.24 billion yen (19.34 billion U.S. dollars). Enditem<\/p>\n\n\n\n
Source: http:\/\/www.xinhuanet.com\/english\/asiapacific\/2021-06\/25\/c_1310027645.htm<\/p>","protected":false},"excerpt":{"rendered":"
TOKYO, June 25 (Xinhua) — Tokyo stocks closed higher Friday following an upbeat lead from Wall Street overnight, although concerns over Japan’s rising COVID-19 cases ahead of the Olympics to be held in the capital in less than a month capped gains. The 225-issue Nikkei Stock Average added 190.95 points, […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[28,5],"tags":[],"class_list":["post-2380","post","type-post","status-publish","format-standard","hentry","category-covid-19","category-news"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2248,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/29\/japan-set-to-extend-virus-emergency-for-tokyo-other-regions-to-june-20\/","url_meta":{"origin":2380,"position":0},"title":"Japan set to extend virus emergency for Tokyo, other regions to June 20","author":"Visa China","date":"29 5 \u6708, 2021","format":false,"excerpt":"source: XInhua TOKYO - The Japanese government on Friday will likely extend COVID-19 emergency measures in place for Tokyo and and eight other prefectures for another three weeks until June 20, local media reported. The state of emergency currently in place for the nine prefectures has seen restrictions imposed on\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/Japan-set-to-extend-virus-emergency.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2441,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/09\/china-takes-lead-at-intl-forum-addressing-covid-19-vaccine-inequality-media\/","url_meta":{"origin":2380,"position":1},"title":"China takes lead at int’l forum addressing COVID-19 vaccine inequality: media","author":"Visa China","date":"9 8 \u6708, 2021","format":false,"excerpt":"HONG KONG, Aug. 9 (Xinhua) -- China is playing a leading role in addressing the widening gap in the distribution of COVID-19 vaccines between richer and poorer countries, said an opinion piece published in the South China Morning Post recently. China will strive to provide 2 billion COVID-19 vaccine doses\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2380,"position":2},"title":"WHO validates China’s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"2 6 \u6708, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2180,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/06\/third-wave-of-covid-19-inevitable-in-india-says-principal-scientific-advisor\/","url_meta":{"origin":2380,"position":3},"title":"Third wave of COVID-19 inevitable in India, says principal scientific advisor","author":"Visa China","date":"6 5 \u6708, 2021","format":false,"excerpt":"By Xinhua NEW DELHI -- A third wave of COVID-19 outbreak is inevitable in India given the higher levels of the circulating virus, said Principal Scientific Advisor to India's Federal Government K. Vijay Raghavan on Wednesday. \"But it is not clear on what time scale this phase three will occur.\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/05\/60933bb9a31024adbdc61241.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/05\/60933bb9a31024adbdc61241.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/05\/60933bb9a31024adbdc61241.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/05\/60933bb9a31024adbdc61241.jpeg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/05\/60933bb9a31024adbdc61241.jpeg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":2421,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/30\/roundup-chinese-covid-19-vaccines-effective-against-infection-mortality\/","url_meta":{"origin":2380,"position":4},"title":"Roundup: Chinese COVID-19 vaccines effective against infection, mortality","author":"Visa China","date":"30 7 \u6708, 2021","format":false,"excerpt":"BUENOS AIRES, July 30 (Xinhua) -- Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. \"According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation\u2026","rel":"","context":"\u7c7b\u4f3c\u6587\u7ae0","block_context":{"text":"\u7c7b\u4f3c\u6587\u7ae0","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2423,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/02\/foreign-officials-experts-oppose-politicizing-covid-19-origin-tracing\/","url_meta":{"origin":2380,"position":5},"title":"Foreign officials, experts oppose politicizing COVID-19 origin tracing","author":"Visa China","date":"2 8 \u6708, 2021","format":false,"excerpt":"BEIJING, Aug. 2 (Xinhua) -- Political leaders and experts worldwide have strongly opposed politicizing the COVID-19 origin tracing issue, saying that such a trend would deal a heavy blow to the global anti-pandemic efforts. \"Research into the origins of the virus is important from a scientific and global health policy\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2380"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2380\/revisions"}],"predecessor-version":[{"id":2381,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2380\/revisions\/2381"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}